Pfizer Inc.

    2021 2020 2019 2018 2017
Operating Cash Flow $32.58B$14.4B$12.59B$15.83B$16.47B
Net Income $21.98B$9.62B$16.27B$11.15B$21.31B
Depreciation & Amortization $5.19B$4.78B$6.01B$6.38B$6.27B
Deferred Income Tax $-4.29B$-1.47B$614M$-2.21B$-2.41B
Stock-Based Compensation $1.18B$756M$718M$949M$840M
Change In Working Capital $12.8B$13.65B$-22.57B$7.35B$2.88B
Other Non-Cash Items $-4.28B$-12.93B$11.54B$-7.81B$-12.42B
Cash From Investing $-22.55B$-4.27B$-3.94B$4.53B$-4.74B
Purchases Of Investments $-47.61B$-14.4B$-7.04B$-13.47B$-18.13B
Sales / Maturities of Investments $28.1B$12.73B$16.34B$19.91B$15.96B
Property, Plant & Equipment Investments $-2.71B$-2.25B$-2.18B$-2.04B$-1.96B
Net Acquisitions $0$0$-10.86B$0$-1B
Other Investing Activites $-318M$-347M$-212M$133M$389M
Cash From Financing $-9.82B$-9.65B$-8.48B$-20.44B$-13.04B
Debt Repayment $-2.1B$-30.33B$-12.63B$-9.62B$-14.74B
Dividend Payments $-8.73B$-8.44B$-8.04B$-7.98B$-7.66B
Payout Ratio 39.72%87.77%49.43%71.53%35.94%
Net Common Stock Repurchased $0$0$8.87B$12.2B$5B
Common Stock Repurchased $0$0$-8.87B$-12.2B$-5B
Common Stock Issued $0$0$8.87B$12.2B$5B
Other Financing Activites $1.01B$29.12B$21.06B$9.36B$14.37B
Accounts Receivables $-3.81B$-1.25B$-742M$-644M$259M
Accounts Payables $1.24B$353M$-564M$431M$46M
Inventory $-1.13B$-736M$-1.05B$-717M$-357M
Other Working Capital $-1.17B$9.15B$-4.5B$18.07B$10.71B
Capital Expenditure (CAPEX) $-2.71B$-2.79B$-2.59B$-2.2B$-2.22B
Effect Of Foreign Exchange On Cash $-59M$-8M$-32M$-116M$53M
Net Change In Cash $158M$475M$125M$-206M$-1.25B
Free Cash Flow (FCF) $29.87B$11.61B$9.99B$13.63B$14.25B
Free Cash Flow To Equity (FCFE) $27.77B$-18.72B$-2.64B$4.01B$-490M

Copyright © 2022 STOCKROUTINES